Integrase strand transfer inhibitors in the management of HIV-positive individuals

Author： Mesplède Thibault Quashie Peter K. Zanichelli Veronica Wainberg Mark A.

ISSN： 0785-3890

Source： Annals of Medicine, Vol.46, Iss.3, 2014-05, pp. : 123-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The strand transfer oligonucleotide inhibitors of HIV-integrase

By Snasel Jan Rosenberg Ivan Paces Ondrej Pichova Iva

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 1, 2009-02 ,pp. : 241-246

Informa Healthcare

Access to resources Recommend Favorite

Drug safety profile of integrase strand transfer inhibitors

By del Mar Gutierrez Maria Mateo Maria Gracia Vidal Francesc Domingo Pere

Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. : 431-445

Informa Healthcare

Access to resources Recommend Favorite

Identification of potential HIV-1 integrase strand transfer inhibitors: In silico virtual screening and QM/MM docking studies

By Reddy K.K. Singh S.K. Tripathi S.K. Selvaraj C.

SAR and QSAR in Environmental Research, Vol. 24, Iss. 7, 2013-07 ,pp. : 581-595

Taylor & Francis Ltd

Access to resources Recommend Favorite

Integrase Strand Transfer Inhibitors and the Emergence of Immune Reconstitution Inflammatory Syndrome (IRIS)

Current HIV Research, Vol. 15, Iss. 6, 2018-01 ,pp. : 405-410

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Studies of N-substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors using 3D-QSAR, Pharmacophore Modeling and Molecular Docking

Letters in Drug Design & Discovery, Vol. 14, Iss. 11, 2017-10 ,pp. : 1291-1302

Bentham Science Publishers

Access to resources Recommend Favorite